YF-VAX 1 dose vials
Ended Awarded
- Contract number
- SPE2DB25FYW90
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,701
Award facts
- Contract value 100% obligated
- $16,701.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,701.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on June 17, 2025, for YF-VAX 1 dose vials with an ultimate completion date of July 10, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499,999,999 single-award vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facility needs worldwide.
YF-VAX is a yellow fever vaccine indicated for individuals traveling to or living in areas where yellow fever transmission is possible, making this delivery order part of the DLA's critical role in maintaining pharmaceutical inventory for Department of Defense healthcare systems globally. DMS Pharmaceutical Group has established itself as a significant supplier in the federal pharmaceutical supply chain, consistently delivering prescription medications, biologics, vaccines, and medical consumables to military and federal healthcare facilities. The firm fixed-price structure and rapid completion timeline reflect the essential nature of vaccine supply chain management for DOD operations.
Quick answers
Who was awarded contract SPE2DB25FYW90?
SPE2DB25FYW90 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 17, 2025.
How much is contract SPE2DB25FYW90 worth?
The government has obligated $16,701 on SPE2DB25FYW90.
Is contract SPE2DB25FYW90 an order under another contract?
Yes. SPE2DB25FYW90 is a delivery order under SPE2DB22D9133, an indefinite delivery contract.
Was contract SPE2DB25FYW90 competed?
The extent of competition for SPE2DB25FYW90 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award